Tenderwize
Retour à la recherche

Contrat de remise pour le pimécrolimus

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Feb 25, 2027 · 96 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Pimecrolimus (ATC: D11AH02).

52/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

52 / 100

Complexité

66 / 100

Facteurs de risque

The provided notice contains no value, volume, utilisation forecast, or guaranteed purchasing commitment, and the agree...

Open-house contracts may end automatically when exclusive rebate contracts enter into force.

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 25, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Conclusion of non-exclusive pharmaceutical rebate agreements for medicines containing Pimecrolimus, ATC D11AH02.
  • Contracting is available under an open-house model to eligible pharmaceutical companies or associations of pharmaceutical companies.
Afficher le résumé complet

Open-house framework-style pharmaceutical rebate agreement for Pimecrolimus (ATC D11AH02) with AOK Niedersachsen, covering Germany from 1 May 2025 to 30 April 2027. Eligible pharmaceutical companies or eligible associations may join on identical terms without a competitive selection decision. The agreement may be terminated early if exclusive rebate contracts enter into force. Contract documents and commercial terms were not provided for analysis, and no contract value is stated.

Risques

The provided notice contains no value, volume, utilisation forecast, or guaranteed purchasing commitment, and the agree...

Open-house contracts may end automatically when exclusive rebate contracts enter into force.

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The participant must be a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG, or an association of pharmaceutical entrepreneurs, in relation to the offered...
  • A pharmaceutical entrepreneur placing medicines on the market within the scope of the AMG must have its registered seat in Germany, another EU Member State, or another EEA...
  • A local representative may participate only if it is itself a pharmaceutical entrepreneur within the meaning of Section 4(18) AMG for the relevant medicines.

Critères d'attribution

Lot 1

Price is identified as the award criterion, but no description or weighting is provided. The notice states that no selection decision is made in the open-house model.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Pimecrolimus Pharmaceutical Rebate Agreement

Non-exclusive rebate agreement under Section 130a(8) SGB V for medicinal products containing Pimecrolimus (ATC D11AH02), operated under an open-house model. The buyer intends to contract with as many eligible pharmaceutical companies or associations as possible on identical, generally non-negotiable terms. Contracts may be concluded during the term, but all contracts end no later than 30 April 2027 and may end earlier if exclusive agreements take effect.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Feb 25, 2027

Détails de la procédure

Date de publication
02 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
138178-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy